×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| GENOMIC VALLEY BIOTECH LIMITED | 2.21 | 1.55 | 2.20 | 0.51 | 18.6 | 46.6 |
| Span Divergent Limited | 23.26 | -2.11 | 18.96 | -0.39 | 17.7 | 12.2 |
| Parmax Pharma Limited | 62.97 | -3.95 | 62.84 | NA | 16.2 |
GENOMIC VALLEY BIOTECH LIMITED, with Security Code 539206, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.0 | 0.6 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 |
| Expenses | 0.1 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
| Operating Profit | 0.0 | 0.0 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 |
| OPM % | -147.62% | 5.06% | 95.08% | 44.07% | 35.29% | 56.41% | 45% | 81.94% | 68.78% | 70.91% |
| Other Income | 0.1 | -0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Profit before tax | 0.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 |
| Tax % | 0% | 0% | 0.1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 0.1 | -0.9 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 |
| EPS in Rs | 0.2 | -2.79 | 3.21 | 0.09 | 0.08 | 0.07 | -0.15 | 0.42 | 0.48 | 0.51 |
| Metrics |
|---|
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit |
| EPS in Rs |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | -30% |
| 3 Years: | -7% |
| TTM: | -50% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -39% |
| 3 Years: | 27% |
| TTM: | -61% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 47% |
| 3 Years: | 34% |
| 1 Year: | 66% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|